LPA and diabetic kidney disease: Although plasma Lp(a) levels have been consistently reported to be lower in individuals with T2DM than in nondiabetic controls, compelling evidences suggest that higher circulating Lp (a) levels in individuals with T2DM are markedly related to higher odds of CVD and diabetic nephropathy and retinopathy (16–21).